Innovative Hemostasis Device HemoSonics offers the cutting-edge Quantra System, a point-of-care viscoelastic testing device that provides rapid and accurate coagulation assessments, making it highly valuable for perioperative and emergency medical settings seeking fast, reliable diagnostics.

Award-Winning Technology The company has received multiple prestigious awards, including the Edison Silver Award and the Medical Device Network Excellence Award, highlighting its reputation for innovation and excellence in medical device development—an attractive quality for healthcare providers seeking trusted solutions.

Strong Market Recognition With recent honors such as the TIME Best Inventions and Fast Company Most Innovative Companies awards, HemoSonics is positioned as a leading innovator, offering sales teams an opportunity to target forward-thinking healthcare facilities looking for state-of-the-art diagnostic tools.

Growing Industry Presence Recognized as part of the Deloitte Fast 500 and with an expanding customer base, HemoSonics demonstrates substantial growth potential, making it a strategic prospect for partners interested in high-growth medical device markets.

Focused on Critical Care Specializing in acute bleeding management and perioperative diagnostics, the company offers solutions ideal for hospitals, trauma centers, and surgical centers aiming to improve patient outcomes with faster, precise coagulation testing—creating targeted sales opportunities in critical care environments.